FeesSafety
Pluang+

Strategy hints at more bitcoin buys after recent $142.7M purchase, raising speculation of further accumulation.

Market News
04 Oct 2026, 17:10 WIB
Bitcoin
View Source
Bullish
Strategy hints at more bitcoin buys after recent $142.7M purchase, raising speculation of further accumulation.

Strategy Inc., led by Michael Saylor, has sparked speculation of additional bitcoin purchases after sharing an updated acquisition chart showing 847,666 BTC valued at about $72.29 billion. The company recently disclosed a $142.7 million bitcoin purchase covering 1,665 BTC made in late September. This follows two consecutive weekly acquisitions and suggests ongoing accumulation funded partly through share sales. Strategy aims to grow its bitcoin treasury while balancing financing needs and dividend obligations, signaling a continued commitment to expanding its bitcoin holdings.

Michael Saylor's Strategy Inc. and its bitcoin accumulation provide context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 04, 2026 20:41 WIB: out of 50 priced assets, 32 rose and 17 fell. Notably, XTZ (Tezos) gained 3.90% with 87% buy order activity and a typical hold time of 100 days, contrasting with KSM (Kusama), which dropped 3.64% and has a typical hold time of 80 days. LTC (Litecoin) also rose 2.75% with 83% buy orders and a hold time of 78 days.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
39 minutes ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
39 minutes ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
2 hours ago
Olin Corp remains a Buy with 20%+ upside, backed by price hikes and strong cash flow despite market challenges.

Olin Corp remains a Buy with 20%+ upside, backed by price hikes and strong cash flow despite market challenges.

Olin Corporation is rated a Buy with over 20% upside potential due to self-help measures and attractive free cash flow yield. Despite facing weak markets and pressures from Chinese exports, Olin's Q3 results showed margin protection through price inc...

Market News
Bullish
5 hours ago
Whitecap Resources posts strong Q3, raises dividend and production outlook after merger benefits

Whitecap Resources posts strong Q3, raises dividend and production outlook after merger benefits

Whitecap Resources reported strong third-quarter results driven by higher oil prices and synergies from a recent merger of two undervalued companies. The company raised its monthly dividend to C$0.0617 per share, reflecting solid free cash flow and d...

Company Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App